These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2090472)

  • 1. Bronchial response to nebulized antibiotics in children with cystic fibrosis.
    Chua HL; Collis GG; Le Souëf PN
    Eur Respir J; 1990 Nov; 3(10):1114-6. PubMed ID: 2090472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy of salbutamol and sodium cromoglycate in the prevention of ticarcillin-induced bronchoconstriction.
    Chua HL; Walker SL; LeSouëf PN; Sly PD
    Pediatr Pulmonol; 1993 Nov; 16(5):311-5. PubMed ID: 8255636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
    N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nebulized colistin versus tobramycin in the treatment of chronic Pseudomonas colonization in cystic fibrosis patients].
    Quintana-Gallego E; Lopez-Campos JL; Calero C; Dapena FJ
    Med Clin (Barc); 2014 Jan; 142(2):59-63. PubMed ID: 23369499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized, controlled trial.
    Gupta S; Ahmed F; Lodha R; Gupta YK; Kabra SK
    J Trop Pediatr; 2012 Oct; 58(5):375-81. PubMed ID: 22374985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalation of tobramycin in patients with cystic fibrosis: comparison of two methods.
    Dopfer R; Brand P; Müllinger B; Hunger T; Häussermann S; Meyer T; Scheuch G; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):141-54. PubMed ID: 18204125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bronchial constriction in children with cystic fibrosis after inhaling two different preparations of tobramycin.
    Alothman GA; Alsaadi MM; Ho BL; Ho SL; Dupuis A; Corey M; Coates AL
    Chest; 2002 Sep; 122(3):930-4. PubMed ID: 12226034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study.
    Westerman EM; Le Brun PP; Touw DJ; Frijlink HW; Heijerman HG
    J Cyst Fibros; 2004 Mar; 3(1):23-8. PubMed ID: 15463883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled tobramycin and bronchial hyperactivity in cystic fibrosis.
    Ramagopal M; Lands LC
    Pediatr Pulmonol; 2000 May; 29(5):366-70. PubMed ID: 10790248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis.
    Mukhopadhyay S; Staddon GE; Eastman C; Palmer M; Davies ER; Carswell F
    Respir Med; 1994 Mar; 88(3):203-11. PubMed ID: 8209069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis.
    O'Connell OJ; O'Farrell C; Harrison MJ; Eustace JA; Henry MT; Plant BJ
    Respir Care; 2011 Jun; 56(6):771-5. PubMed ID: 21333079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R; Metcalfe C; Wallis C; Bush A
    Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo.
    McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Taneja A; Murphy P; Goldmann DA
    J Infect Dis; 1983 Mar; 147(3):559-67. PubMed ID: 6339649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of inhaled tobramycin in patients with cystic fibrosis].
    Chermenskiĭ AG; Gembitskaia TE
    Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis.
    Dodd ME; Abbott J; Maddison J; Moorcroft AJ; Webb AK
    Thorax; 1997 Jul; 52(7):656-8. PubMed ID: 9246141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Area under the maximum expiratory flow-volume curve--a sensitive parameter in the evaluation of airway patency.
    Zapletal A; Hladíková M; Chalupová J; Svobodová T; Vávrová V
    Respiration; 2008; 75(1):40-7. PubMed ID: 17299253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebulisers comparison with inhaled tobramycin in young children with cystic fibrosis.
    Clavel A; Boulaméry A; Bosdure E; Luc C; Lanteaume A; Gorincour G; Stremler-Lebel N; Sarles J; Andrieu V; Dubus JC
    J Cyst Fibros; 2007 Apr; 6(2):137-43. PubMed ID: 16839826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchial constriction and inhaled colistin in cystic fibrosis.
    Alothman GA; Ho B; Alsaadi MM; Ho SL; O'Drowsky L; Louca E; Coates AL
    Chest; 2005 Feb; 127(2):522-9. PubMed ID: 15705991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoconstriction following nebulised colistin in cystic fibrosis.
    Cunningham S; Prasad A; Collyer L; Carr S; Lynn IB; Wallis C
    Arch Dis Child; 2001 May; 84(5):432-3. PubMed ID: 11316693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.